CN1331456C - 口腔组合物 - Google Patents
口腔组合物 Download PDFInfo
- Publication number
- CN1331456C CN1331456C CNB2004800025732A CN200480002573A CN1331456C CN 1331456 C CN1331456 C CN 1331456C CN B2004800025732 A CNB2004800025732 A CN B2004800025732A CN 200480002573 A CN200480002573 A CN 200480002573A CN 1331456 C CN1331456 C CN 1331456C
- Authority
- CN
- China
- Prior art keywords
- oral cavity
- cavity composition
- chalk
- perlite
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 239000010451 perlite Substances 0.000 claims abstract description 42
- 235000019362 perlite Nutrition 0.000 claims abstract description 42
- 210000000214 mouth Anatomy 0.000 claims description 58
- 238000005498 polishing Methods 0.000 claims description 23
- 239000002245 particle Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000000227 grinding Methods 0.000 description 6
- 230000003370 grooming effect Effects 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- -1 halogenated bisphenol compound Chemical class 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical group NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000000498 ball milling Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000004579 marble Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001044369 Amphion Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229920002118 antimicrobial polymer Polymers 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 108700023668 bacilysin Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- AZSFNUJOCKMOGB-UHFFFAOYSA-K cyclotriphosphate(3-) Chemical compound [O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-K 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- AXLHVTKGDPVANO-UHFFFAOYSA-N methyl 2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound COC(=O)C(N)CNC(=O)OC(C)(C)C AXLHVTKGDPVANO-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GTQFPPIXGLYKCZ-UHFFFAOYSA-L zinc chlorate Chemical compound [Zn+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O GTQFPPIXGLYKCZ-UHFFFAOYSA-L 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/01—Chemical elements
- H01L2924/01011—Sodium [Na]
Abstract
一种包含珍珠岩的口腔组合物，其特征在于该口腔组合物还包含白垩。
Description
本发明提供一种具有改善的磨损效果的口腔组合物。
WO02/45676(Hawe Neos)披露了一种具有磨损组分的清洁剂，用于清洗易损表面，尤其是牙齿。其优选通过使用例如玻璃鳞片的组分来完成。
EP0528756(Hawe Neos)披露了一种基本上无水的牙科护理和清洁组合物.该组合物包含精细粉碎的岩石(其可以是珍珠岩的形式)和1，2-丙二醇以及至少一种用于岩石颗粒的润湿剂的形式.要求精细粉碎的岩石已经经过了一种昂贵筛分方法的筛分，以确保其为均匀的混合物，并且足够细小，以便不引起过度磨损就可以有效清洁。
US5124143(Muhlemann)披露了一种包含硅酸和珍珠岩的洁牙剂.该组合物为牙科保健员使用的具有预防口腔卫生性质的糊剂提供了出乎意料的高研磨性.
US 6355227(unilever)披露了一种包含0.01％-0.9％w/w珍珠岩的口腔组合物.
WO99/31184(Crosfield)披露了一种液体产品，其混合了高密度无机颗粒和密度小于水的颗粒共附聚的颗粒形式的材料，以修改粒料的密度和有助于其浮力。
尽管在现有技术中已经存在上述这些口腔组合物，但是仍然需要一种口腔组合物，其能够改善抛光，同时又不会增加磨损度或口腔组合物的相对牙磨损(RDA)。
已经发现在口腔组合物中同时提供珍珠岩和白垩有助于牙齿抛光。该组合可以增强口腔组合物从牙齿上去除粘附污物、释放易受影响的牙斑、去除易受影响的碎屑和去除表面污迹的能力，这又可以改善口感和利于牙齿洁白。
根据本发明，提供一种含有白垩的口腔组合物，其特征在于该口腔组合物中还含有珍珠岩.
珍珠岩包含平滑的或相对平坦的颗粒，其在研磨后由锯齿状边缘、蛋壳状的碎片构成，这些碎片在使用时被打碎成更小的碎片。
珍珠岩的物理结构意味着珍珠岩颗粒在受到例如刷牙时牙刷的压力时，它的平面结构能确保定向其本身平行于工作表面。该作用随着压力的增加而增强。在表面和沉积物间滑动的平滑颗粒，可以沿着宽表面小心地去除沉积物，这样可以减小磨损效果。
然而该效果会被没有打碎的单个融合珍珠岩之间三角拱肩的形成所妨碍。如果这些三角拱肩是立体的，那么它们的形成能够导致其接触的表面有更多的刮痕，并在负荷下没有达到平滑效果，从而产生问题。因此，这将会增加掺入这些颗粒的制剂的磨损度.
令人惊奇地，我们已经发现，珍珠岩可以加入到包含白垩的口腔组合物中，而不会增加该组合物的总磨损度。这是通过珍珠岩和白垩之间令人惊奇的相互作用完成的。在口腔组合物中，白垩与任意珍珠岩三角拱肩的锯齿边缘相结合并使其变平滑。因此，在包含白垩的口腔组合物中加入珍珠岩能够在不增加磨损度的情况下增加口腔组合物的抛光能力。
因此，在口腔组合物中与白垩颗粒结合的珍珠岩颗粒在其与口腔接触时破坏表面例如牙齿及与软组织的可能性小得多。在口腔组合物中与白垩颗粒结合的珍珠岩颗粒显著增加口腔组合物的清洁能力，这样它们的组合可以用于改善抛光而不会产生由过度磨损导致的损害.
术语口腔组合物是本领域已知的，包括洁牙剂、牙膏、软锭剂、胶、锭剂、漱口水及其他。
根据本发明，口腔组合物中的珍珠岩可以是本领域通常已知的任何珍珠岩或珍珠岩混合物。可以是粗制或非膨胀珍珠岩.优选为膨胀珍珠岩，其可被快速加热到871℃以上，以进行膨胀并随后冷却。
珍珠岩优选磨损值用RDA表示为125-150(J Dent Res 37：1060-1068，1958 or J Dent Res 55：563 to 573，1976)。优选珍珠岩是E50珍珠岩，可取自Worldminerals Italia srl.，，Alzaia Trento 6，20094Corsico，Milano，Italy.
珍珠岩的加权中位数粒径可以是10μm-50μm。优选加权中位数粒径为20μm-45μm.最优选加权中位数粒径为30μm-40μm。
优选90重量％的珍珠岩的粒径小于70μm-110μm.优选10重量％的珍珠岩的粒径小于7μm-10μm.珍珠岩的粒度分布可以由激光散射(Malvern 3600E，300mm Lens)测定。
根据本发明的另一实施方案，提供一种口腔组合物，其中，珍珠岩在该口腔组合物中为0.01重量％-20重量％。
在口腔组合物中珍珠岩为0.5重量％-15重量％，优选0.7重量％-10重量％.最优选珍珠岩占口腔组合物的1重量％-5重量％。
珍珠岩组合物优选包含SiO270-75％w/w，Al2O310-15％w/w，Fe2O30.5-1％w/w，Na2O4-5％w/w，K2O7-9％w/w，CaO0.2-0.4％w/w，MgO0.05-1.5％w/w，TiO20.05-1.5％w/w。
令人惊奇地，在包含珍珠岩的口腔组合物中加入白垩能够减少口腔组合物中珍珠岩可能具有的负面影响。珍珠岩包含大量不同金属，通常会危害口腔组合物中的一些重要成分的稳定性。某些成分例如一氟磷酸钠是白垩糊剂的选用氟化物。然而令人惊奇地，一氟磷酸钠的稳定性没有因为珍珠岩中各种金属的存在而受到危害。
口腔组合物也包含占组合物重量5％-60％的白垩，优选占组合物重量15％-55％。更优选白垩占口腔组合物重量的20％-50％。最优选白垩占口腔组合物重量的25％-45％.
白垩包含碳酸钙，口腔组合物中的碳酸钙可浸析出碳酸根离子。这些碳酸根离子又会发生反应，结果使金属离子从珍珠岩中浸析出来。令人惊奇地，这种相互作用减少了口腔组合物中由于使用相对高水平的珍珠岩而具有的负面影响.
白垩与用于口腔组合物的替代磨料，例如二氧化硅相比，也具有更活泼的化学反应性.因此，白垩的这些性质能够阻止浸析出的金属离子对包含珍珠岩和白垩的口腔组合物产生副作用。
根据本发明的另一个实施方案，提供一种口腔组合物，其中白垩是精细研磨的天然白垩。
精细研磨的天然白垩可以取自天然存在的石灰石或大理石沉积物，其在研磨前已经形成超过数百万年的时间。研磨可以是球磨，接着过筛，然后根据需要的性质进行选择.精细研磨的天然白垩也可以在研磨时或研磨后采用热处理方法通过包衣进行化学的或物理的改性。典型的包衣包括硬脂酸镁或油酸镁.精细研磨的天然白垩的形态可以通过不同的研磨技术、不同的研磨方法进行改变，例如球磨、空气分级器研磨和螺旋喷射研磨。
精细研磨的天然白垩意味着该白垩是源自研磨石灰石或大理石沉积物，而不是经过合成沉淀出来的。
精细研磨的天然白垩不合可以干扰珍珠岩抛光效果的硬的和软的白垩块。因此，精细研磨的白垩可以使珍珠岩的锯齿边缘变平滑，其方式是其他磨料例如二氧化硅难以获得的。令人惊奇地，使用越小颗粒可以对具有有益于抛光效果的珍珠岩边缘产生越小的干扰.
优选白垩的供应厂商为Omya，产品优选为5AV.特别地产品可以是Omya10微米.优选90重量％的白垩的粒径小于20μm。优选50重量％的白垩的粒径小于4μm-8μm。
可选择地，白垩的供应厂商为Wolkchem，产品是Addon1015.优选90重量％的白垩的粒径小于20μm.优选50重量％的白垩的粒径小于4μm-8μm.精细研磨的天然白垩的BET表面积范围是0.5-3m2/g.
根据本发明的另一实施方案，提供一种如任一项前述权利要求所述的口腔组合物，其中口腔组合物的pH值为8-14。
在一个优选的实施方案中，口腔组合物的pH值为9-13，优选10-12。最优选口腔组合物的pH值为11。
提高含有珍珠岩的口腔组合物的pH值会减少金属离子从珍珠岩中析出。这意味着这些金属离子对口腔组合物可能具有的负面影响，例如与一氟磷酸钠反应、染色等等会减少。
根据本发明的一个实施方案，提供一种如任一项前述权利要求所述的口腔组合物，其相对牙磨损(RDA)为140-170。
相对牙磨损为150-160，优选152-158。最优选相对牙磨损为155.
牙膏的磨损度可以根据Journal of Dental Research(1976)55(4)，563所述的实验设计进行测量.其描述了如何对相对牙磨损(RDA)进行评价。
根据本发明的另一实施方案，提供一种如任一项前述权利要求所述的口腔组合物，其具有的抛光百分比为60-95。
优选抛光百分比为70-90.最优选抛光百分比为75-85。
抛光百分比是指每一圆盘的抛光百分率.如何对各个圆盘的抛光百分率进行评价的方法将在下面进行讨论.
评价抛光效力的试验是在学术文献中已知的，例如J.G Masters，A Zaccagnino，R，Heu和M.Stranic k.J Dent.Res.81 Spec Iss AAbs.2152(2002).抛光试验一般在羟基磷灰石(HAP)圆盘上进行.选择该材料因为它具有与牙釉质相似的性质，并可以以适宜的圆盘形式获得。在用所试验的牙膏糊剂刷拭之前，圆盘用砂纸预先擦亮到一个设定的光泽度。该试验通过测定经过刷拭的HAP瓦制品的光泽度来评价糊剂的抛光性.光泽测定可以采用Sheen Tri-microgloss meter在60deg/60deg(λ射角/测量角)下进行。
每个测试产品选用4个HAP圆盘，每个瓦制品都采用科萨茹图形在WIRA刷拭机(Goodbrand Jeffrys Mark III磨损试验器)上刷拭。向每个圆盘施加的重量为375g，刷拭速度为150rpm，并使用标准中等头牙刷。光泽测定在1000，5000，10000，15000个行程时进行。每个瓦制品在同一模版下在每个时间点进行四次测量，以使每次测量都在相同的点上进行.
用于每次产品测试的牙膏浆体可以如下制备，加入1份糊剂，1份蒸馏水(微孔水)和1份SCMC稀释剂。其中SCMC稀释剂包括5％甘油，0.5％SCMC 7m，0.01％福尔马林和94.49％微孔水。
该浆体用heidolph end over搅拌器混合30分钟以确保在用于研究前所有的糊剂都充分地混合。
各个圆盘的抛光百分比是由刷拭后的圆盘的平均光泽度除以相同圆盘的平均基线光泽度，然后乘以100得到的。其结果就是实验2中详述的数字或者叫作抛光百分比。该结果作为每个圆盘的抛光百分比详细列于实验2中。在Excel软件中进行统计分析，显示其Student′st-检验的显著性差异为p＜0.05.
根据本发明的另一方面，提供珍珠岩在前述任一项权利要求所述的用于抛光牙齿的口腔组合物中的用途.
根据本发明的口腔组合物包含本领域常用的其他组分，例如：抗微生物剂，如三氯生、氯己定、铜盐、锌盐及亚锡盐，如柠檬酸锌、硫酸锌、甘氯酸锌、柠檬酸锌钠及焦磷酸亚锡、血根碱提取物、甲硝唑、季铵化合物，如氯化十六烷基吡啶；双胍，如二葡萄糖酸氯己定、海克替啶、奥替尼啶、阿来克定；及卤化的双酚化合物，如2，2’-亚甲基双-(4-氯-6-溴苯酚)；
消炎剂，例如布洛芬、氟比洛芬、阿司匹林、吲哚美辛等；抗龋齿剂，例如氟化钠及氟化亚锡、氟化胺、一氟磷酸钠、三偏磷酸钠及酪蛋白；
牙斑缓冲剂例如尿素、乳酸钙、甘油磷酸钙及聚丙烯酸锶；
维生素例如维生素A、C及E；
植物提取物；
脱敏剂，例如柠檬酸钾、氯化钾、酒石酸钾、碳酸氢钾、草酸钾、硝酸钾及锶盐；
防牙垢剂，例如，焦磷酸的碱金属盐、含次磷酸的聚合物、有机磷酸盐和磷酸柠檬酸盐等；
生物分子，例如杆菌素、抗体、酶等；
芳香剂，例如薄荷及薄荷油；
蛋白质材料例如角蛋白及胶原；
防腐剂；
不透明剂；
着色剂；
pH调节剂；
甜味剂；
药学可接受的载体，例如淀粉、蔗糖、水或水/醇体系等；表面活性剂，例如，阴离子、非离子、阳离子及两性离子或两性表面活性剂；
颗粒研磨材料例如二氧化硅、氧化铝、磷酸氢钙、二水合磷酸氢钙、焦磷酸钙、羟基磷灰石、三偏磷酸盐、不溶性六偏磷酸盐等，包括附聚的颗粒研磨材料，通常在口腔护理组合物中为3-60重量％。
稀释剂例如甘油、山梨醇、丙二醇、木糖醇、乳糖醇等，山梨醇在口腔组合物中可以最高达50重量％；
粘合剂和增稠剂，例如羧甲基纤维素钠、黄原胶、阿拉伯胶等，以及合成的聚合物，例如聚丙烯酸酯和羧乙烯基聚合物，如Carbopol；可以增强活性组分如抗微生物剂递送的聚合体化合物也可包括在内。这些聚合体的例子包括聚乙烯基甲基醚与马来酸酐的共聚物及其他类似的增强递送的聚合物，如在DE-A-3,942,643(Colgate)中所述的聚合物；
用于缓冲口腔护理组合物的pH值和离子强度的缓冲剂和盐；以及其他任选的组分，可以包括例如，漂白剂，如过氧化合物，例如过氧二磷酸钾；泡腾体系，例如碳酸氢钠/柠檬酸体系；变色体系；抗氧化剂，例如α-硫辛酸等.
脂质体也可以用于改善活性组分的递送或稳定性.
参照以下的非限制性实施例对本发明作进一步的说明。
实验1：
下面的口腔组合物是本发明的一个实例。
| 组分 | 占总重量的百分比 |
| 白垩 | 40 |
| 增稠性二氧化硅 | 3 |
| SLS | 2.6 |
| 珍珠岩 | 0.7 |
| 一氟磷酸钠 | 0.76 |
| TiO2 | 0.5 |
| 福尔马林 | 0.1 |
| 芳香剂 | 1.1 |
| 糖精 | 0.23 |
| 水 | 补足至100 |
实验2：
相对牙磨损(RDA)
| 组分 | RDA |
| 占总重量40％的精细研磨的天然白垩 | 150 |
| 占总重量40％的精细研磨的天然白垩加占总重量0.7％的珍珠岩 | 155 |
抛光
| 组分 | 每一圆盘的抛光百分比 |
| 占总重量40％的精细研磨的天然白垩 | 49.5 |
| 占总重量40％的精细研磨的天然白垩加占总重量0.7％的珍珠岩 | 83.4 |
口腔组合物中精细研磨的天然白垩具有特殊的相对牙磨损.其不会由于将珍珠岩加入到精细研磨的天然白垩中而显著增加.而精细研磨的天然白垩和珍珠岩的组合提供了明显增强的抛光作用。这些结果显示含有珍珠岩和精细研磨的天然白垩的组合能在不增加相对牙磨损的情况下改善抛光。
Claims (6)
1.一种包含白垩的口腔组合物，其特征在于该口腔组合物还包含珍珠岩，珍珠岩在该口腔组合物中为0.01重量％-20重量％，并且白垩在该口腔组合物中为5重量％-60重量％。
2.权利要求1的口腔组合物，其中白垩为精细研磨的天然白垩。
3.权利要求1或2的口腔组合物，其中该口腔组合物的pH值为8-14。
4.权利要求1或2的口腔组合物，其相对牙磨损为140-170。
5.权利要求1或2的口腔组合物，其“抛光百分比”为60-95。
6.珍珠岩在权利要求1-5任一项的用于抛光牙齿的口腔组合物中的用途。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03075233 | 2003-01-22 | ||
| EP03075233.1 | 2003-01-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1741783A CN1741783A (zh) | 2006-03-01 |
| CN1331456C true CN1331456C (zh) | 2007-08-15 |
Family
ID=32748895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004800025732A Expired - Lifetime CN1331456C (zh) | 2003-01-22 | 2004-01-09 | 口腔组合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060182694A1 (zh) |
| EP (1) | EP1585491B1 (zh) |
| CN (1) | CN1331456C (zh) |
| BR (1) | BRPI0406466A (zh) |
| CL (1) | CL2004000084A1 (zh) |
| PL (1) | PL211248B1 (zh) |
| RU (1) | RU2322967C2 (zh) |
| WO (1) | WO2004064795A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885796B1 (fr) * | 2005-05-19 | 2010-12-24 | Philippe Morin | Eclat dentaire jeunesse |
| US8518380B2 (en) * | 2006-12-29 | 2013-08-27 | Kerrhawe Sa | Prophylactic cleaning product and method of packaging |
| TWI458497B (zh) | 2010-01-13 | 2014-11-01 | Colgate Palmolive Co | 口腔組成物中氧化鋅薄膜之安定化 |
| EE05823B1 (et) | 2015-02-27 | 2020-07-15 | IltEnko Valeri | Diafragmaelektrolüüser |
| CN106236597B (zh) * | 2016-08-16 | 2019-03-19 | 好来化工(中山)有限公司 | 一种口腔护理组合物及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976506A (en) * | 1994-09-21 | 1999-11-02 | Chesebrough-Pond's Usa Co. | Oral compositions |
| WO2001085114A1 (en) * | 2000-05-09 | 2001-11-15 | Unilever N.V. | Oral composition |
| CN1352397A (zh) * | 2000-09-05 | 2002-06-05 | Atg试验体系两合公司 | 测试电路板的方法和设备 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4678662A (en) * | 1985-10-09 | 1987-07-07 | Monsanto Company | Pyrophosphate coating process for calcium carbonate dental abrasives |
| DK0630227T3 (da) * | 1993-01-14 | 1999-10-25 | Weissenfluh Hawe Neos | Tandpasta |
| EP1050293A1 (de) * | 1999-05-06 | 2000-11-08 | HAWE NEOS DENTAL Dr. H. V. WEISSENFLUH AG | Zahnpflegemittel |
| ATE232081T1 (de) * | 1999-06-04 | 2003-02-15 | Unilever Nv | Orale zusammensetzung enthaltend perlit |
| US6432387B1 (en) * | 2000-03-23 | 2002-08-13 | Create Co., Ltd. | Ionic tooth polishing agent |
| PL373913A1 (en) * | 2001-10-02 | 2005-09-19 | Unilever N.V. | Oral composition comprising fine ground natural chalk |
-
2004
- 2004-01-09 RU RU2005126406/15A patent/RU2322967C2/ru active
- 2004-01-09 WO PCT/EP2004/000145 patent/WO2004064795A1/en active Application Filing
- 2004-01-09 PL PL377147A patent/PL211248B1/pl unknown
- 2004-01-09 BR BR0406466-6A patent/BRPI0406466A/pt not_active Application Discontinuation
- 2004-01-09 CN CNB2004800025732A patent/CN1331456C/zh not_active Expired - Lifetime
- 2004-01-09 EP EP04701005.3A patent/EP1585491B1/en not_active Expired - Lifetime
- 2004-01-09 US US10/543,153 patent/US20060182694A1/en not_active Abandoned
- 2004-01-21 CL CL200400084A patent/CL2004000084A1/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976506A (en) * | 1994-09-21 | 1999-11-02 | Chesebrough-Pond's Usa Co. | Oral compositions |
| WO2001085114A1 (en) * | 2000-05-09 | 2001-11-15 | Unilever N.V. | Oral composition |
| CN1352397A (zh) * | 2000-09-05 | 2002-06-05 | Atg试验体系两合公司 | 测试电路板的方法和设备 |
Also Published As
| Publication number | Publication date |
|---|---|
| CL2004000084A1 (es) | 2005-05-06 |
| PL377147A1 (pl) | 2006-01-23 |
| RU2005126406A (ru) | 2006-02-27 |
| US20060182694A1 (en) | 2006-08-17 |
| CN1741783A (zh) | 2006-03-01 |
| WO2004064795A1 (en) | 2004-08-05 |
| BRPI0406466A (pt) | 2005-12-06 |
| PL211248B1 (pl) | 2012-04-30 |
| RU2322967C2 (ru) | 2008-04-27 |
| EP1585491B1 (en) | 2014-10-22 |
| EP1585491A1 (en) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101377083B1 (ko) | 실리카 | |
| CN100408016C (zh) | 口腔组合物 | |
| RU2431464C2 (ru) | Композиция средства для чистки зубов, не содержащая алкилсульфата и ортофосфата, содержащая источник фторида и абразив для зубов на основе диоксида кремния | |
| JP7195308B2 (ja) | 新規組成物 | |
| TW201609156A (zh) | 新穎組合物 | |
| Dionysopoulos et al. | Effect of air-abrasion pre-treatment with bioactive glass 45S5 on enamel surface loss after erosion/abrasion challenge | |
| CN1331456C (zh) | 口腔组合物 | |
| CN110997071A (zh) | 促进牙齿再矿化的方法 | |
| EP2533751B1 (en) | Composition for cleaning teeth comprising natural glass and related methods | |
| US20100291163A1 (en) | Oral care composition comprising nanoparticulate titanium dioxide | |
| HU228797B1 (hu) | Perlitet tartalmazó orális kompozíciók és perlit alkalmazása tisztítószerként ilyen kompozíciókban | |
| CN1960704B (zh) | 用于抑制牙侵蚀的含有氢氟酸的组合物 | |
| EP3082719B1 (en) | Dentifrice composition comprising spherical fused alumnium oxide particles | |
| WO2015140060A1 (en) | Novel composition | |
| CN1225234C (zh) | 包含与活性成分共研磨的载体的水基牙膏 | |
| US6436372B2 (en) | Oral composition with abrasive mixture of chalk and carbide | |
| CN117715618A (zh) | 口腔护理组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210824 Address after: Rotterdam Patentee after: Unilever Intellectual Property Holdings Ltd. Address before: Rotterdam Patentee before: Unilever Nederland B.V. |
|
| TR01 | Transfer of patent right | ||
| CX01 | Expiry of patent term |
Granted publication date: 20070815 |
|
| CX01 | Expiry of patent term |